Evidence map›Paper›PMID 29142244›Full record

ArticleInternational journal of obesity (2005)2018

Body size phenotypes comprehensively assess cardiometabolic risk and refine the association between obesity and gut microbiota.

J de la Cuesta-Zuluaga, V Corrales-Agudelo, J A Carmona, J M Abad, J S Escobar

Abstract read
PubMed Publisher
In one paragraph

Article in International journal of obesity (2005), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 3 pooled it
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 3 syntheses or guidelines pooled it, 66 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Differential effects of high-fat diet on salivary and gut microbiota.Frontiers in cellular and infection microbiology · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. [Gut Microbiota and Obesity].The Korean journal of helicobacter and upper gastrointestinal research · 2023
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

J de la Cuesta-ZuluagaVidarium, Nutrition, Health and Wellness Research Center, Grupo Empresarial Nutresa, Medellin, Colombia.
V Corrales-AgudeloVidarium, Nutrition, Health and Wellness Research Center, Grupo Empresarial Nutresa, Medellin, Colombia.
J A CarmonaDinámica IPS, Especialista en Ayudas Diagnósticas, Medellin, Colombia.
J M AbadEPS SURA, Medellin, Colombia.
J S EscobarVidarium, Nutrition, Health and Wellness Research Center, Grupo Empresarial Nutresa, Medellin, Colombia.
Vidarium - Centro de Investigación en Nutrición Salud y BienestarFundación Con Vida · CO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe gut microbiota associates with obesity and related disorders, but recent meta-analyses have found that this association is, at best, of small effect. We argue that such analyses are flawed by the use of body mass index (BMI) as sole proxy for disease, and explore a classification method that distinguishes the cardiometabolic health status of individuals to look for more comprehensive associations between gut microbes and health.

designWe analyzed a 441 community-dwelling cohort on which we obtained demographic and health information, anthropometry and blood biochemistry data that served to categorize participants according to BMI, cardiometabolic health status and body size phenotypes. In addition, the participants donated fecal samples from which we performed 16S rRNA gene sequencing to analyze the gut microbiota.

resultsWe observed that health-related variables deteriorate with increased BMI, and that there are further discrepancies within a given BMI category when distinguishing cardiometabolically healthy and unhealthy individuals. Regarding the gut microbiota, both obesity and cardiovascular disease associate with reductions in α-diversity; having lean, healthy individuals the most diverse microbiotas. Moreover, the association between the gut microbiota and health stems from particular consortia of microbes; the prevalence of consortia involving pathobionts and Lachnospiraceae are increased in obese and cardiometabolically abnormal subjects, whereas consortia including Akkermansia muciniphila and Methanobrevibacter, Oscillospira and Dialister have higher prevalence in cardiometabolically healthy and normoweight participants.

conclusionsThe incorporation of cardiometabolic data allows a refined identification of dissimilarities in the gut microbiota; within a given BMI category, marker taxa associated with obesity and cardiometabolic disease are exacerbated in individuals with abnormal health status. Our results highlight the importance of the detailed assessment and classification of individuals that should be carried out prior to the evaluation of obesity treatments targeting the gut microbiota.

Indexed as

AdultBlood PressureBody Mass IndexBody SizeCohort StudiesFemaleGastrointestinal MicrobiomeHumansMaleMiddle AgedObesityPhenotypeRiskSmoking

Identifiers

PMID29142244
OpenAlexW2769938637

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.